| Integrated genomic characterization of endometrial carcinoma DA Levine, ... Nature 497 (7447), 67-73, 2013 | 4203 | 2013 |
| Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018 | 1974 | 2018 |
| Genomic and molecular landscape of DNA damage repair deficiency across The Cancer Genome Atlas TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ... Cell reports 23 (1), 239, 2018 | 722 | 2018 |
| Genomic and Functional Approaches to Understanding Cancer Aneuploidy AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ... Cancer Cell, 2018 | 693 | 2018 |
| Pathogenic germline variants in 10,389 adult cancers K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ... Cell 173 (2), 355-370. e14, 2018 | 611 | 2018 |
| A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers AC Berger, A Korkut, RS Kanchi, AM Hegde, W Lenoir, W Liu, Y Liu, ... Cancer Cell, 2018 | 470 | 2018 |
| Standards and guidelines for validating next-generation sequencing bioinformatics pipelines: a joint recommendation of the Association for Molecular Pathology and the College … S Roy, C Coldren, A Karunamurthy, NS Kip, EW Klee, SE Lincoln, A Leon, ... The Journal of Molecular Diagnostics 20 (1), 4-27, 2018 | 357 | 2018 |
| Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer GE Konecny, C Wang, H Hamidi, B Winterhoff, KR Kalli, J Dering, ... JNCI: Journal of the National Cancer Institute 106 (10), 2014 | 327 | 2014 |
| Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ... PLoS genetics 9 (3), e1003212, 2013 | 319 | 2013 |
| Integrated molecular characterization of uterine carcinosarcoma AD Cherniack, H Shen, V Walter, C Stewart, BA Murray, R Bowlby, X Hu, ... Cancer Cell 31 (3), 411-423, 2017 | 316 | 2017 |
| Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseases M Allen, MM Carrasquillo, C Funk, BD Heavner, F Zou, CS Younkin, ... Scientific data 3 (1), 1-10, 2016 | 289 | 2016 |
| Genomic, pathway network, and immunologic features distinguishing squamous carcinomas JD Campbell, C Yau, R Bowlby, Y Liu, K Brennan, H Fan, AM Taylor, ... Cell reports 23 (1), 194, 2018 | 253 | 2018 |
| Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer EL Goode, MS Block, KR Kalli, RA Vierkant, W Chen, ZC Fogarty, ... JAMA oncology 3 (12), e173290-e173290, 2017 | 232 | 2017 |
| Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2 and RAD51C status JM Cunningham, MS Cicek, NB Larson, J Davila, C Wang, MC Larson, ... Scientific reports 4 (1), 1-7, 2014 | 146 | 2014 |
| Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma E Loeuillard, J Yang, ELN Buckarma, J Wang, Y Liu, C Conboy, ... The Journal of clinical investigation 130 (10), 5380-5396, 2020 | 134 | 2020 |
| Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular SubtypesResponse to Bevacizumab by Ovarian Cancer … S Kommoss, B Winterhoff, AL Oberg, GE Konecny, C Wang, SM Riska, ... Clinical Cancer Research 23 (14), 3794-3801, 2017 | 105 | 2017 |
| Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel MS Cicek, DC Koestler, BL Fridley, KR Kalli, SM Armasu, MC Larson, ... Human molecular genetics 22 (15), 3038-3047, 2013 | 95 | 2013 |
| Pooled Clustering of High-Grade Serous Ovarian Cancer Gene Expression Leads to Novel Consensus Subtypes Associated with Survival and Surgical OutcomesOvarian Cancer Subtypes … C Wang, SM Armasu, KR Kalli, MJ Maurer, EP Heinzen, GL Keeney, ... Clinical Cancer Research 23 (15), 4077-4085, 2017 | 87 | 2017 |
| MACE: model based analysis of ChIP-exo L Wang, J Chen, C Wang, L Uusküla-Reimand, K Chen, A Medina-Rivera, ... Nucleic acids research 42 (20), e156-e156, 2014 | 84 | 2014 |
| Prognostic gene expression signature for high-grade serous ovarian cancer J Millstein, T Budden, EL Goode, MS Anglesio, A Talhouk, ... Annals of Oncology 31 (9), 1240-1250, 2020 | 80 | 2020 |
Brooke L FridleyMoffitt Cancer CenterVerified email at moffitt.org
